Milestone Pharmaceuticals (MIST) Free Cash Flow (2018 - 2026)
Milestone Pharmaceuticals (MIST) posted Free Cash Flow of -$16.1 million for Q1 2026, down 23.28% on a QoQ basis from -$13.1 million in Q4 2025, and down 15.33% year-over-year from -$19.0 million in Q1 2025.
Milestone Pharmaceuticals (MIST) Free Cash Flow (2018 - 2026) Analysis & Trends
Milestone Pharmaceuticals' Free Cash Flow history runs 9 years deep, the most recent figure standing at -$16.1 million for Q1 2026.
- Quarterly Free Cash Flow fell 15.33% year-over-year to -$16.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$51.5 million (down 51.88% YoY) and the FY2025 annual result came in at -$49.3 million, down 70.85% from the prior year.
- Free Cash Flow was -$16.1 million for Q1 2026 at Milestone Pharmaceuticals, down from -$13.1 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$6.1 million in Q2 2024 and bottomed at -$16.1 million in Q1 2026.
- A 5-year average of -$11.4 million and a median of -$12.2 million in 2023 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow tumbled 1487.68% — and 2024, when it surged 42.87%.
- Milestone Pharmaceuticals' Free Cash Flow stood at -$13.0 million in 2022, then grew by 24.24% to -$9.8 million in 2023, then soared by 30.14% to -$6.9 million in 2024, then slumped by 90.21% to -$13.1 million in 2025, then decreased by 23.28% to -$16.1 million in 2026.
- Business Quant data shows MIST's Free Cash Flow at -$16.1 million in Q1 2026, -$13.1 million in Q4 2025, and -$9.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Milestone Pharmaceuticals | 156.34 Mn | -27.87 Mn | - | -16.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.10 Mn |
| Mar 31, 2026 | -16.10 Mn |
| Dec 31, 2025 | -13.06 Mn |
| Dec 31, 2025 | -13.06 Mn |
| Sep 30, 2025 | -9.75 Mn |
| Sep 30, 2025 | -9.75 Mn |
| Jun 30, 2025 | -12.58 Mn |
| Jun 30, 2025 | -12.58 Mn |
| Mar 31, 2025 | -13.96 Mn |
| Mar 31, 2025 | -13.96 Mn |
| Dec 31, 2024 | -6.87 Mn |
| Dec 31, 2024 | -6.87 Mn |
| Sep 30, 2024 | -7.02 Mn |
| Sep 30, 2024 | -7.02 Mn |
| Jun 30, 2024 | -6.05 Mn |
| Jun 30, 2024 | -6.05 Mn |
| Mar 31, 2024 | -8.93 Mn |
| Mar 31, 2024 | -8.93 Mn |
| Dec 31, 2023 | -9.83 Mn |
| Dec 31, 2023 | -9.83 Mn |